RM
Robert Michael Bacci
About Robert Michael Bacci
Data last updated:
Robert Michael Bacci is a Director at Nektar Therapeutics (India) Private Limited (since 2024). The company operates in Pharma. Nektar Therapeutics (India) Private Limited reported revenue of ₹3.39 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nektar Therapeutics (India) Private Limited U24239TG2005FTC046253 | Director | 18 Jun 2024 | 2005 | ₹3.39 Cr (FY 2025) | Active |
Board colleagues of Robert Michael Bacci
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mark Andrew Wilson | 08391710 | Nektar Therapeutics (India) Private Limited | Director |
| Phaneendra Modali | Nektar Therapeutics (India) Private Limited | Company Secretary | |
| Uday Chandra Yemmanuru | 01581364 | Nektar Therapeutics (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Robert Michael Bacci
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Robert Michael Bacci
Robert Michael Bacci currently holds 1 directorship: Nektar Therapeutics (India) Private Limited (Director, since 18 Jun 2024, revenue ₹3.39 Cr (FY 2025)).
Robert Michael Bacci was first appointed on 18 Jun 2024 as Director at Nektar Therapeutics (India) Private Limited.
The current boards of Robert Michael Bacci's companies include Mark Andrew Wilson (Nektar Therapeutics (India) Private Limited), Phaneendra Modali (Nektar Therapeutics (India) Private Limited), Uday Chandra Yemmanuru (Nektar Therapeutics (India) Private Limited).